Annaswamy Raji

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 5

Top Topics

Metabolic Syndrome

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Silvina Gallo, Roberto A Calle, Steven G Terra, Annpey Pong, Lisa Tarasenko, Annaswamy Raji
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (8) (2020)
Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam, Edward A O'Neill, Keith D Kaufman, Samuel S Engel
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (10) (2020)
Silvina Gallo, Annaswamy Raji, Roberto A Calle, Annpey Pong, Christian Meyer
The effects of ertugliflozin on β-cell function: Pooled analysis from four phase 3 randomized controlled studies. Diabetes, obesity & metabolism 22 (12) (2020)
Annaswamy Raji, Jianmin Long, Raymond L H Lam, Edward A O'Neill, Samuel S Engel
Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (4) (2018)
Russell Scott, Jerry Morgan, Zachary Zimmer, Raymond L H Lam, Edward A O'Neill, Keith D Kaufman, Samuel S Engel, Annaswamy Raji
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study. Diabetes, obesity & metabolism 20 (12) (2018)